UBS Lux Equity Fund Biotech USD vs Atlant Stability

UBS Lux Equity Fund Biotech USD vs Atlant Stability

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

2. Atlant Stability

  • Security

    Atlant Stability

  • Fee

    0.50%

  • ISIN

    SE0002623553

  • Holdings

    20

Fund Holdings

We have information about 11 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Vertex (8.44). In comparison with Atlant Stability, we have 1 holdings where is the largest holding (8.89), followed by (3.16) and (3.03).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Atlant Stability.

UBS Lux Equity Fund Biotech USD Atlant Stability
1. Regeneron Pharmaceuticals Inc
10.04 %
1.
8.89 %
2. Moderna Inc
9.21 %
2.
3.16 %
3. Vertex Pharmaceuticals Inc
8.44 %
3.
3.03 %
4. Alnylam Pharmaceuticals Inc
8.08 %
4.
2.86 %
5. AbbVie Inc
USA
4.91 %
5.
2.42 %
6. Gilead Sciences Inc
USA
4.66 %
6.
2.15 %
7. Amgen Inc
USA
4.43 %
7.
2.08 %
8. BioNTech SE
4.13 %
8.
1.98 %
9. Karuna Therapeutics Inc
3.75 %
9.
1.87 %
- 10.
1.76 %
- 11.
1.65 %
- 12.
1.65 %
- 13.
1.54 %
- 14.
1.49 %
- 15.
1.47 %
- 16.
1.46 %
- 17.
1.44 %
- 18.
1.4 %
- 19.
1.35 %
- 20.
1.31 %

The list of fund holdings was last updated on July 25, 2025.